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Abstract  
Argemone ochroleuca Sweet (Papaveraceae) is used to treat eye infection, respiratory and dermatological disorders in Tepotzotlán, State of México (México). 
The aim of this work was to investigate antimicrobial activity of hexane, ethyl acetate and methanol extracts from aerial parts of A. ochroleuca. The 
antimicrobial activity was evaluated against thirteen bacteria and nine fungal strains. Only methanol extract showed antimicrobial activity. S. aureus (MIC= 
125 µg/mL) and C. neoformans (MIC= 500 µg/mL) were the most sensitive strains. The bioassay-guide purification of the methanolic extract resulted in the 
isolation and identification of the isoquinoline alkaloid berberine. The present study confirms the antimicrobial activity of methanolic extract of A. 
ochroleuca.  
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Resumen 
Infusiones de la parte aérea de Argemone ochroleuca Sweet (Papaveraceae) son utilizadas por los pobladores de Tepotzotlán, Estado de México, para el 
tratamiento de infecciones en los ojos, enfermedades respiratorias y dermatológicas. El objetivo de este trabajo fue investigar la actividad antimicrobiana de 
los extractos hexánicos, acetato de etilo y metanólico de la parte aérea de A. ochroleuca. La actividad antimicrobiana fue evaluada frente a trece cepas 
bacterianas y nueve cepas fúngicas. Solo el extracto metanólico presentó actividad antimicrobiana. S. aureus (MIC= 125 µg/mL) y C. neoformans (MIC= 500 
µg/mL) fueron las cepas que presentaron mayor sensibilidad. La purificación biodirigida del extracto metanólico dio como resultado el aislamiento e 
identificación del alcaloide isoquinolínico berberina. El presente estudio confirma la actividad antimicrobiana del extracto metanólico de A. ochroleuca.  
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INTRODUCTION 
A. ochroleuca Sweet (Papaveraceae) is known as 
"chicalote", and is a weed native of North America, 
widely spread from southern USA to central México 
(Martinez, 1996). It is used in traditional medicine by 
the inhabitants of Tepotzotlán, State of Mexico. Based 
on information obtained from healers in the region is 
known that infusions of the aerial part are used to 
relieve eye infections, (Neri, 1995), spots, and warts, 
combat insomnia, cough and dermatological disorders 
(Argueta & Cano, 1994). A. ochroleuca is an annual or 
perennial herb of short life (Rzedowski & Rzedowski, 
2001). 
There are some publications about the 
chemical composition of A. ochroleuca and it have 
been identified fatty acids (Fletcher et al., 1993), 
flavonoids (Stermitz et al., 1969, Bhardwaj et al., 
1982, Saleh et al., 1987, Fletcher et al., 1993; Chang 
et al., 2003) and several alkaloids such as atropine, 
berberine (Espinosa & Sarukhan, 1997), chelerythrine, 
protopine, sanguinarine, dihidrosanguinarine, 
dihidroquelerithrina, α-allacriptopine, heleritrine, 
queilantifoline, scouletrine, reticuline and copsitine 
(Haisova & Slavik, 1973; Israilov et al., 1986; 
Chelombit'ko & Nazarova 1988; Takken et al., 1993).  
The purpose of this study was to evaluate the 
antimicrobial activity of hexane, ethyl acetate and 
methanol extracts from aerial parts of A. ochroleuca. 
 
MATERIALS AND METHODS 
Plant Material 
Flowering specimens of A. ochroleuca were collected 
in September 2007 in Tepotzotlán, State of Mexico. 
Voucher specimens were deposited in the National 
Herbarium of Mexico (MEXU) at the Universidad 
Nacional Autónoma de Mexico, and the herbarium 
IZTA at the Facultad de Estudios Superiores Iztacala 
(Voucher n° 41638).  
 
Preparation of the Extracts 
Air-dried aerial part (7 days at room temperature, 1 
kg) of the plant was extracted with solvents of 
different polarity: hexane, ethyl acetate and methanol. 
The extracts were filtered, successively concentrated 
and kept in dark at 4 °C until tested. The extracts 
yields were: hexane 1.77 % w/w, ethyl acetate 3.22 % 
w/w and for methanol 10.03 % w/w. 
 
Microbial Strains  
The following strains of bacteria were used: Vibrio 
cholerae INDRE 206 (isolated from polluted water), 
Vibrio cholerae (clinical strain pertaining to 01 grup, 
Inaba serotype, “El Tor” biotype, and enterotoxin 
producer), Vibrio cholerae CDC V 12, Escherichia 
coli ATCC 25922, Enterobacter agglomerans ATCC 
27155, Salmonella typhi ATCC 19430, and 
Staphylococcus aureus (ATCC 12398). All the strains 
tested were maintained at 4 °C in Mueller Hinton Agar 
and were subcultured every month. Enterobacter 
aerogenes (cephalosporin and ampicillin resistant), 
Vibrio cholerae No-01 (ampicillin resistant), 
Staphylococcus epidermidis (ampicillin, cephotaxim 
and dicloxacillin resistant), Sarcina lutea (cephotaxim 
and dicloxacillin resistant) and Bacillus subtilis 
(cephalothin, penicillin, cephotaxim and dicloxacillin 
resistant) were donated by the Laboratory of 
Microbiology of FES-Cuautitlán, Yersinia 
enterocolitica (ampicillin resistant) was donated by the 
Clinical Analysis Laboratory of University Hospital 
Campus Iztacala. These strains were maintained at 4 
°C in Mueller Hinton agar, submitted to sensitivity 
tests (multidiscs Bigaux) and were subcultured every 
month.  
Nine fungal pathogens were used: Fusarium 
sporotrichum ATCC NRLL 3299, Aspergillus niger, 
Trichophyton mentagrophytes, Fusarium moniliforme 
were donated by Dr. Cesar Flores (Laboratory of Plant 
Physiology of UBIPRO, FES-Iztacala), and 
Rhyzoctonia solani was donated by Dr. Raul 
Rodriguez (INIFAP-Texcoco). Candida albicans 
ATCC 14065, ATCC 10231, Candida albicans 
(clinical strain), were donated by the Clinical Analysis 
Laboratory of University Hospital Campus Iztacala. 
Cryptococcus neoformans, donated by the Mycology 
and Parasitology Laboratory of Medicine, UNAM. 
The stock culture was maintained on Czapek Dox 
Agar (Sigma).  
 
Antibacterial Activity 
The antibacterial activity was measured by the disc-
diffusion method (Vanden Berghe & Vlietinck, 1991). 
The microorganisms were grown overnight at 37 °C in 
10 mL of Mueller Hinton Broth (Bioxon). The 
cultures were adjusted with sterile saline solution to 
obtain turbidity comparable to that of McFarland no. 
0.5 standard (Lennett et al., 1987). Petri dishes 
containing Mueller Hinton agar (Bioxon) were 
inoculated with these microbial suspensions. Discs of 
filter paper (Whatman Nº 5) of 5 mm diameter were 
impregnated with 2000 μg of each extract and placed 
on the agar surface. Disks impregnated with 10 μL of 
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hexane, ethyl acetate and methanol were used as 
negative controls. Discs with 25 μg (5 μl) of 
chloramphenicol (5 mg/mL Sophia Labs, Mexico) 
were used as positive controls. The plates were 
incubated overnight at 37 °C and the diameter of any 
resulting zones of inhibition (mm) of growth was 
measured. Each experiment was repeated three times.  
The estimation of the Minimal Inhibitory 
Concentration (MIC) and Minimal Bactericidal 
Concentration (MBC) were carried out by the broth 
dilution method (Vanden Berghe & Vlietinck, 1991). 
Dilutions of the extracts from 2000-7 μg/mL were 
used. Test bacteria culture was used at the 
concentration of 105 CFU/mL. MIC values were taken 
as the lowest extract concentration that prevents 
visible bacterial growth after 24 h of incubation at 37 
°C, and MBC as the lowest concentration that 
completely inhibited bacterial growth.  
Chloramphenicol was used as reference and 
appropriate controls with no extract were used. Each 
experiment was repeated three times.  
The bactericidal kinetic assay was performed 
by using appropriate concentrations of the methanolic 
extract (corresponding to ½ MIC, MIC and MBC), in 
accordance with the method described by Avila et al., 
1999.  
 
Antifungal Activity 
For yeast we used the method described for bacteria, 
using Petri dishes containing Czapek Dox Agar (20 
mL), Nystatin (30 μg) was used as reference and 
appropriate controls with no extract were used. Each 
experiment was repeated three times.  
The assay of antifungal activity was carried 
out in Petri dishes containing Czapek Dox Agar (20 
mL). After the mycelial colony had developed, sterile 
blank paper disks (5 mm diameter) were placed at a 
distance of 0.5 cm away from the rim of the mycelial 
colony. An aliquot of 2000 μg of each extract were 
added to disks. Ketoconazole was used as reference 
and appropriate controls with no extracts were used. 
The Petri dishes were incubated at 23 °C for 72 h until 
mycelial growth had enveloped. Disks containing 
samples and had formed crescents of inhibition were 
considerate with antifungal activity (Ye et al., 1999). 
 
General toxicity assay 
The general toxicity in vivo brine shrimp lethality test 
was carried out by using brine shrimp Artemia salina 
(Leach) larvae, according to the methodology 
described by McLaughin (1991). The methanolic 
extract was tested at 1000, 100 and 10 ppm (μg/mL) 
and also evaluated by triplicate. 
Samples were prepared by dissolving the 
extract in DMSO. The final DMSO concentration did 
not exceed 1% which has been shown not to have any 
harmful effects on the larvae. As positive control, 
gallic acid was used (LC50 =321.5 μg/mL); and as 
negative control DMSO was used. Survivors were 
counted after 24 h. LC50 was determined from 24 h 
counts. The general toxicity activity was considered 
weak when the LC50 was between 500 and 1000 
μg/mL, moderate when the LC50 was between 100 and 
500 μg/mL, and strong when the LC50 ranged from 0 
to 100 μg/mL (Padmaja et al., 2002). 
 
Statistical analysis 
All experiments were performed in triplicate. The 
mean and standard deviation of three experiments 
were determined. Statistical analysis of the differences 
between mean values obtained for experimental 
groups was done by analysis of variance (ANOVA 
multifactorial model); p-values of 0.001 or less were 
considered statistically significant. Lethal 
concentration 50 (LC50) values, in the general toxicity 
assay, were calculated by linear regression analysis 
with Microsoft Excel program. 
 
Active compound isolation 
For the separation of the active compound, column 
chromatography (silica gel mesh 70-230 Sigma 5-
2509) was used. The methanolic extract (70 g) was 
chromatographed on silica gel column and was eluted 
with the following gradient of solvents chloroform-
methanol (10:0, 9:1, 8,2, 7:3, 6:4, 5:5, 4:6, 3:7, 2:8, 
1:9, 0:10); obtaining thirty-two collected fractions. 
The purification of the active compound was making 
by assay-guided isolation. The antibacterial activity of 
all collected fractions was measured by disc-diffusion 
method (Vanden Berghe & Vlietinck, 1991). Fractions 
16-20 were active. The purification of the active 
compound was made by recrystalization in chloroform 
and methanol. The yield obtained of the active 
compound at the end of the process was of 18.9 mg.  
The active compound was identified by: 
melting point 144-146 °C; IR ART (Perkin Elmer to 
FT-IR Spectrum 2000), 3421cm-1 assignable to a 
tertiary amine belonging to a heterocyclic; 2993-2849 
cm-1 assignable to –CH, -CH2 and CH3,1506 cm-1 
assignable to double bonds of an aromatic compound, 
1274 cm-1 assignable to C-O (methoxyl group); and at 
1103 cm-1 a sign that suggests the presence of a cyclic 
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esther; and confirmed with X-ray crystallography 
(Bruker AXS-Detector de Area con Radiaciones 
MoKalfa; (Kariuki and Jones, 1995). 
 
RESULTS 
The results obtained in the evaluation of the 
antimicrobial activity of the methanolic extract of A. 
ochroleuca are shown inTable 1.  
 
Table 1. Antimicrobial and general toxicity activities (MIC’s, IC50 and LD50) of A. ochroleuca. 
 Positive controls (μg/mL)  
Organism Chloramphenicol Gallic acid Nystatine Methanolic 
extract (μg/mL) 
Artemia 
salina 
- 321.5 - 10 
Sa 1 - - 125 
Se 2 - - 500 
Sl 1 - - >2000 
Bs 2 - - 250 
Vch No01 1 - - 1500 
Vch Tor 1 - - 1500 
Cn - - 4 500 
Ca - - 4 1750 
 
Artemia salina (LD50 values); bacteria (MIC’s values); Fungi (IC50 values); Sa, Staphylococcus aureus; Se, Staphylococcus 
epidermidis; Bs, Bacillus subtilis; Sl, Sarcina lutea; Vch No-01, Vibrio cholerae; Vch Tor, Vibrio cholerae CDC V12; Cn, 
Cryptococcus neoformans;  Ca, Candida albicans (clinical strain). The hexane and ethyl acetate extracts showed no activity. sd 
± 0.0 in all cases.  
 
Only the methanolic extract showed 
antibacterial activity in four Gram positive and two 
Gram negative bacteria strains.  
S. aureus was the strains more sensitive to the 
methanolic extract effect (MIC=125 μg/mL). In 
general Gram positive bacteria (MIC=125 - 500 
μg/mL) were more sensitive than the Gram negative 
ones (MIC=1500 μg/mL). 
Only the methanolic extract showed antifungal 
activity in C. neoformans and C. albicans (clinical 
case). C. neoformans was the strain more sensitive to 
the methanolic extract effect (IC50=500 μg/mL).  
 
Figure 1 and 2 show the effect of the 
methanolic extract (in the survival curve) on a Gram-
positive bacterium (S. aureus) and in a fungal strain 
(C. albicans isolated of a clinical case). Minimum 
inhibitory concentrations (MIC) had a bacteriostatic 
effect on the microbial population, while the minimum 
bactericidal concentrations (MBC) had a lethal effect 
on bacteria and in the fungal strain within the first 
twelve and five hours respectively.  
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Figure 1. Survival curve of Staphylococcus aureus exposed to methanol extract of A. ochroleuca. 
 
The methanol extract was added to each experimental culture in zero time. The concentrations used were: 62.5 µg/mL (½ 
MIC), 125 µg/mL (MIC), 250 µg/mL (MBC). The control tube did not contain methanol extract. 
 
 
Figure 2. Survival curve of Candida albicans (clinical strain) exposed to methanol extract of A. ochroleuca. 
 
The methanol extract was added to each experimental culture in zero time. The concentrations used were: 875 µg/mL (½ MIC), 
1750 µg/mL (MIC), 3500 µg/mL (MBC). The control tube did not contain methanol extract. 
 
The general toxicity activity (Table 1) was 
considered strong for the methanolic extract of A. 
ochroleuca against A. salina (LC50 = 10 μg/mL).  
IR spectra and the X-Ray Cristallography 
showed that the structure of the active compound is 
the isoquinoline alkaloid berberine (Figure 3). 
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Figure 3. Perspective view of the X-ray structure of the Berberine 
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DISCUSSION 1969, Bhardwaj et al., 1982, Saleh et al., 1987, 
Only de methanolic extract of A. ochroleua presented 
antibacterial activity against four Gram positive and 
two Gram negative bacteria. It was observed that S. 
aureus presented the lowest values of MIC. In general 
Gram positive bacteria were more sensitive than the 
Gram negative ones (Inbaraj et al., 2001; Freile et al., 
2003; Sepulveda-Jimenez et al., 2004; Enriz & Freile, 
2006; Abdel-Sattar et al., 2010; Alamri & Moustafa, 
2010).  
Fletcher et al., 1993; Chang et al., 2003).  
The general toxicity activity of the methanolic 
extract was considerate strong. It is important to 
observe that in some cases bigger concentrations to 
LD50 are required to inhibit the growth of some 
bacterial and fungal strains, but as we know local 
people use infusions of the aerial part of A. ochroleuca 
to treat infectious diseases.  
 
The methanolic extract of A. ochroleuca 
presented antifungal activity against two strains. It was 
observed that C. neoformans (MIC=500 μg/mL) was 
the most sensitive strain (Table 1). 
CONCLUSION 
The present study confirms the antimicrobial activity 
of methanolic extract of A. ochroleuca.  
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